Moreover, treatment with rosoxacin, a quinolone derivative antibiotic and a specific inhibitor for IRAK1, led to suppression of autoimmune hypophysitis with reduced production of autoantigen-specific antibodies, cytokines, and chemokines that may dampen T-cell differentiation or recruitment to the pituitary [15]. The gene discussed is IRAK1; the disease is primary hypophysitis.